| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/13/2009 | WO2009099716A1 Novel vaccines against multiple subtypes of dengue virus |
| 08/13/2009 | WO2009098410A1 Leporipoxvirus-derived vaccine vectors |
| 08/13/2009 | WO2009098277A1 Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
| 08/13/2009 | WO2009079308A3 Composition and method of use of sheep fab phage display library |
| 08/13/2009 | WO2009050573A3 Viral modification of reoviridae |
| 08/13/2009 | WO2009036933A3 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 08/13/2009 | US20090203885 Astrocyte Modulated Genes And Uses Thereof |
| 08/13/2009 | US20090203542 Selection system |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090203114 Novel methods and interferon deficient substrates for the propagation of viruses |
| 08/13/2009 | US20090203113 comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; drug delivery |
| 08/13/2009 | US20090203112 Vero cell line which is adapted to grow in suspension |
| 08/13/2009 | US20090203071 Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor |
| 08/13/2009 | US20090202622 Virosome-like vesicles comprising gp41-derived antigens |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides |
| 08/13/2009 | US20090202492 Adenovirus vaccine utilizing ikk as adjuvant |
| 08/13/2009 | US20090202490 Mutant adeno-associated virus virions and methods of use thereof |
| 08/13/2009 | US20090202489 Adenoviruses mutated in the va genes for cancer treatment |
| 08/13/2009 | CA2713400A1 Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines |
| 08/13/2009 | CA2709925A1 Leporipoxvirus-derived vaccine vectors |
| 08/13/2009 | CA2708668A1 Novel vaccines against multiple subtypes of dengue virus |
| 08/12/2009 | EP2087109A2 Stabilization of biological materials through inactivation of metalloenzymes |
| 08/12/2009 | EP2087104A1 Medium supplement for virus production |
| 08/12/2009 | CN101506358A Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments |
| 08/12/2009 | CN101506357A Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 08/12/2009 | CN101504411A Method for screening recombined vaccinia virus containing exogenous fusion gene HIV/gag/IFN alpha-2b |
| 08/12/2009 | CN101503685A Anticancer recombinant adenovirus with tumour cell miR-221/222 as drug target, construction method and use |
| 08/12/2009 | CN101503677A Recombinant adenovirus of Survivin promoter regulated human NIS gene, construction method and use |
| 08/12/2009 | CN101503676A Bemisia tabaci gennadius inoculation method for tomato yellowing leaf curl virus disease |
| 08/11/2009 | US7572906 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
| 08/11/2009 | US7572621 Characterizing hepatitis C viral infection by determining a similarity between a viral sequence of an hypervariable region 1 (HVR1) of the second envelope protein (E2) region of an hepatitis C virus that infected the host and a variable region kappa light chain of an immunoglobulin of the host |
| 08/11/2009 | US7572620 vaccine comprising the virus; immunization; diagnostic method comprising contacting a physiological sample of an animal suspected of containing antiinfluenza virus antibodies with the claimed virus |
| 08/11/2009 | US7572455 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition |
| 08/11/2009 | US7572453 Envelope glycoproteins; capsids; immunogens |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | CA2192940C Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 08/08/2009 | CA2653300A1 Polyvalent vaccine against salmonid alphavirus infections |
| 08/06/2009 | WO2009097129A1 Recombinant virus production using mammalian cells in suspension |
| 08/06/2009 | WO2009095791A1 Reverse genetics of negative-strand rna viruses in yeast |
| 08/06/2009 | WO2009054996A9 Systems and methods for viral therapy |
| 08/06/2009 | US20090197320 Ancestral dengue virus envelope protein |
| 08/06/2009 | US20090197319 Virus-Like Particle Containing A Dengue Recombinant Replicon |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | CA2713338A1 Recombinant virus production using mammalian cells in suspension |
| 08/05/2009 | EP2085479A1 Reverse genetics of negative-strand rna viruses in yeast |
| 08/05/2009 | EP2085468A1 DNA transfection system for the generation of infectious influenza virus |
| 08/05/2009 | EP2084282A2 Uncoupling of dna insert propagation and expression of protein for phage display |
| 08/05/2009 | EP1246913B1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 08/05/2009 | CN101497877A Influenza all-virus attenuated live vaccine recombinant, construction method and use thereof |
| 08/05/2009 | CN101497876A Recombinant adenovirus for expressing targetedly proliferating recombinant adenovirus for expressing proapoptosis gene and use thereof |
| 08/05/2009 | CN100523177C Pig replication and respiration syndrome virus attenuated vaccine strain and uses thereof |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/04/2009 | US7569383 Chimeric flavivirus vectors |
| 08/04/2009 | US7569340 Arrays of site-isolated biological entities; use of direct-write nanolithographic printing; enables a wide variety of studies involving viruses that are not possible with microarrays |
| 08/04/2009 | US7569219 Delivery of recombinant dsRNA phage to eukaryotic cells and tissues, either by direct administration, formulated in lipid or lactide-glycolide copolymer, or by utilizing a bacterial vaccine vector |
| 08/04/2009 | US7569217 Porcine adenovirus E1 and E4 regions |
| 07/30/2009 | WO2009093409A1 Novel mycovirus, attenuated strain of phytopathogenic fungus, plant disease controlling agent, method of producing mycovirus, method of attenuating phytopathogenic fungus and method of controlling plant disease |
| 07/30/2009 | WO2008109686A8 Non- infectious recombinant virus-like particles and their pharmaceutical applications |
| 07/30/2009 | US20090191555 HCV NS3-NS4 Protease Resistance Mutants |
| 07/30/2009 | US20090191240 Flavivirus Vaccines |
| 07/30/2009 | US20090191239 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/30/2009 | US20090191238 Method for producing yeast expressed HPV types 6 and 16 capsid proteins |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
| 07/30/2009 | US20090191157 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2082042A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/29/2009 | EP0879284B1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 07/29/2009 | CN101495624A Modified AAV vectors having reduced capsid immunogenicity and use thereof |
| 07/29/2009 | CN101492657A Swine fever live vaccine ST cell culture method |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/28/2009 | US7566562 Culturing circular ssDNA viruses for the production of vaccines |
| 07/23/2009 | WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 07/23/2009 | WO2009042202A3 Formulations for preservation of rota virus |
| 07/23/2009 | WO2009014782A3 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 07/23/2009 | US20090186842 Methods and compositions for inhibition of viral replication |
| 07/23/2009 | US20090186396 Enhanced purification of phosphorylated and nonphosphorylated biomolecules by apatite chromatography |
| 07/23/2009 | US20090186050 Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains |
| 07/23/2009 | US20090186046 Hepatitis C Virus Non Structural Fusion Protein |
| 07/23/2009 | US20090186023 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions |
| 07/23/2009 | US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2009 | US20090185997 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/23/2009 | DE102008005193A1 Bakteriophagenpräparation und Verwendung Bacteriophage preparation and use |
| 07/22/2009 | EP1597359B1 Inactivated nodavirus vaccine |
| 07/22/2009 | EP1471937B1 A continuous cell line for the production of vaccines |
| 07/22/2009 | EP1432791B1 Alphavirus replicon vector systems |
| 07/22/2009 | EP1297110B1 Attenuated bovine respiratory syncytial virus |
| 07/22/2009 | EP0870013B1 Systems and methods for removing viral agents from blood |
| 07/22/2009 | CN101490248A Method for influenza virus purification |
| 07/22/2009 | CN101486997A Fowlpox virus rFPV-AIH5/IL2, construction method and use thereof |
| 07/22/2009 | CN100516221C Nucleotide sequences of mutant swine fever viral strin, polypeptides encoded by these squences and use thereof |
| 07/22/2009 | CN100516206C Reovirus vaccine and its preparing method |
| 07/21/2009 | US7563881 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 07/21/2009 | US7563878 Bacterial phytases and method for producing same |
| 07/21/2009 | US7563617 Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
| 07/21/2009 | US7563449 Methods for reducing cattle reproductive diseases |
| 07/21/2009 | US7563448 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 07/16/2009 | WO2009089121A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |